{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T05:47:37Z","timestamp":1662788857481},"reference-count":34,"publisher":"The University of Occupational and Environmental Health, Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J UOEH"],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.7888\/juoeh.44.293","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T22:15:49Z","timestamp":1662675349000},"page":"293-299","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Angioimmunoblastic T-cell Lymphoma (AITL)"],"prefix":"10.7888","volume":"44","author":[{"given":"Ayaka","family":"KANEOKA","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"AKAMATSU","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Japan Community Health Care Organization, Shimonoseki Medical Center."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"HARA","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Occupational and Environmental Health, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"SUGIYAMA","sequence":"additional","affiliation":[{"name":"Department of Hematology, Japan Community Health Care Organization, Shimonoseki Medical Center."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"SETOGUCHI","sequence":"additional","affiliation":[{"name":"Department of Pathology, Japan Community Health Care Organization, Shimonoseki Medical Center."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4637","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 . Chihara D, Ito H, Matsuda T <i>et al <\/i>(2014): Differences in incidence and trends of haematological malignancies in Japan and the United States.  Br J Haematol 164 (4): 536\u2212545","DOI":"10.1111\/bjh.12659"},{"key":"2","unstructured":"2 . \u672c\u544a\u5321\uff0c\u8c37\u7530\u90e8\u606d \uff082014\uff09\uff1a\u8840\u7ba1\u514d\u75ab\u82bd\u7403\u6027\uff34\u7d30\u80de\u6027\u30ea\u30f3\u30d1\u816b\uff0e\u30ea\u30f3\u30d1\u816b\u30a2\u30c8\u30e9\u30b9\uff0e\u6539\u8a02\u30fb\u6539\u984c\u3000\u7b2c4\u7248\uff08\u5927\u5cf6\u5b5d\u4e00\uff0c\u4ed6\uff0c\u7de8\uff09\uff0c\u6587\u5149\u5802\uff0c\u6771\u4eac pp 216\u2212218"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 . Dogan A, Attygalle AD & Kyriakou C (2003): Angioimmunoblastic T-cell lymphoma.  Br J Haematol 121 (5): 681\u2212691","DOI":"10.1046\/j.1365-2141.2003.04335.x"},{"key":"4","unstructured":"4 . Dogan A, Gaulard P, Jaffe ES, et al (2008): Angioimmunoblastic T-cell Lymphoma, WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4<sup>th<\/sup> ed. IARC Press, Lyon 309\u2212311"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 . Swerdlow SH, Campo E, Pileri SA<i> et al<\/i> (2016): The 2016 revision of the World Health Organization classification of lymphoid neoplasms.  Blood 127 (20): 2375\u22122390","DOI":"10.1182\/blood-2016-01-643569"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 . Dorfman DM, Brown JA, Shahsafaei A & Freeman GJ (2006): Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma.  Am J Surg Pathol 30 (7): 802\u2212810","DOI":"10.1097\/01.pas.0000209855.28282.ce"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 . Miyoshi H, Sato K, Niino D<i> et al<\/i> (2012): Clinicopathologic analysis of peripheral T-Cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-Cell lymphoma: Bcl-6 expression might affect progression between these disorders.  Am J Clin Pathol 137 (6): 879\u2212889","DOI":"10.1309\/AJCPBPNV86VZENGV"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 . Dupuis J, Boye K, Martin N<i> et al<\/i> (2006): Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-Cell lymphoma (AITL): A new diagnostic marker providing evidence that AITL derives from follicular helper T Cells.  The Am J Surg Pathol 30 (4) 490\u2212494","DOI":"10.1097\/00000478-200604000-00009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 . Martel P, Laroche L, Courville P<i> et al<\/i> (2000): Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: A clinical, immunohistological, and molecular analysis.  Arch Dermatol 136 (7): 881\u2212886","DOI":"10.1001\/archderm.136.7.881"},{"key":"10","unstructured":"10 . \u5d6f\u5ce8\u8ce2\u6b21\uff0c\u672c\u9593\u5149\u4e00\uff0c\u52a0\u85e4\u5149\u5b50\uff081983\uff09: \u76ae\u819a\u306b\u5f62\u8cea\u7d30\u80de\u3068\u514d\u75ab\u82bd\u7d30\u80de\u306e\u8457\u660e\u306a\u6d78\u6f64\u3092\u8a8d\u3081\u305fAngioimmunoblastic Lymphadenopathy\u306e1\u4f8b\uff0e\u76ae\u819a\u79d1\u306e\u81e8\u5e8a 25 \uff0813\uff09: 1305\u22121310"},{"key":"11","unstructured":"11 . \u52a0\u85e4\u54f2\u5b50\uff0c\u5c0f\u95a2\u4f38\uff0c\u5409\u5ddd\u8ce2\u4e00\uff0c\u4ed6\uff081997\uff09: Angioimmunoblastic T-cell lymphoma\u306e1\u4f8b\uff0e\u76ae\u819a\u79d1\u306e\u81e8\u5e8a 39\uff0810\uff09: 1587\u22121590"},{"key":"12","unstructured":"12 . \u5927\u6d25\u5b5d\u679d\uff0c\u9577\u5c3e\u6d0b\uff0c\u677e\u5ca1\u5b5d\uff0c\u570b\u53cb\u5fe0\u7fa9\uff0c\u4eca\u57ce\u5065\u4e8c\uff0c\u5409\u91ce\u6b63\uff081998\uff09: \u591a\u5f69\u306a\u76ae\u75b9\uff0c\u9ad8IgE\u8840\u75c7\uff0c\u597d\u9178\u7403\u5897\u591a\u3092\u4f34\u3063\u305fAngioimmunoblastic T-cell Lymphoma\u306e1\u4f8b\uff0e\u76ae\u819a\u79d1\u306e\u81e8\u5e8a 40 \uff0811\uff09: 1763\u22121766"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 . \u5ddd\u5185\u9ebb\u7f8e\u5b50\uff0c\u6e05\u6c34\u662d\u5f66\uff0c\u53e4\u8cc0\u54f2\u4e5f\uff0c\u5229\u8c37\u662d\u6cbb \uff081998\uff09: \u5168\u8eab\u306e\u7d05\u6591\u304c\u5148\u884c\u3057\u305fAngioimmunoblastic T-cell lymphoma (AILD). \u897f\u65e5\u672c\u76ae\u819a\u79d1 60 \uff084\uff09: 483\u2212486","DOI":"10.2336\/nishinihonhifu.60.483"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 . Sugaya M, Nakamura K, Asahina A & Tamaki K (2001): Leukocytoclastic vasculitis with IgA deposits in angioimmunoblastic T Cell lymphoma.  J Dermatol 28 (1): 32\u221237","DOI":"10.1111\/j.1346-8138.2001.tb00083.x"},{"key":"15","unstructured":"15 . \u829d\u6728\u5149\uff0c\u5c0f\u6c60\u4e14\u5f25\uff0c\u91cc\u608c\u5b50\uff0c\u6afb\u4e95\u5b8f\u6cbb\uff0c\u5742\u4e95\u535a\u4e4b\uff0c\u4eca\u4e95\u967d\u4fca\uff082002\uff09: \u7279\u7570\u75b9\u3092\u4f34\u3063\u305fAngioimmunoblastic T-cell Lymphoma\u306e1\u4f8b\uff0e\u65ed\u5ddd\u539a\u751f\u75c5\u9662\u533b\u8a8c 12 \uff081\uff09: 53\u221257"},{"key":"16","unstructured":"16 . \u4e2d\u6751\u54f2\u53f2\uff0c\u5c71\u672c\u660e\u7f8e\uff0c\u9ad8\u6a4b\u82f1\u4fca\uff0c\u4ed6\uff082002\uff09: Angioimmunoblastic T Cell Lymphoma\u306e1\u4f8b\uff0e\u76ae\u819a\u79d1\u306e\u81e8\u5e8a 44:15\u221219"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 . \u5185\u91ce\u3086\u308a\uff0c\u798f\u4e38\u572d\u5b50\uff0c\u5150\u7389\u4eac\u5b50\uff0c\u5150\u6d66\u7d14\u7fa9\uff0c\u592a\u826f\u5149\u5229\uff0c\u82b1\u7530\u6b63\u660e\uff082002\uff09: Angioimmunoblastic T Cell Lymphoma (AILD)\u306e1\u4f8b\uff0e\u897f\u65e5\u672c\u76ae\u819a\u79d1 64 \uff086\uff09: 722\u2212725","DOI":"10.2336\/nishinihonhifu.64.722"},{"key":"18","unstructured":"18 . \u65e9\u5ddd\u90c1\u5b50\uff0c\u4e2d\u689d\u5712\u5b50\uff0c\u5ddd\u539f\u7e41\uff0c\u7027\u53e3\u54f2\u4e5f\uff0c\u798f\u5cf6\u4fca\u6d0b \uff082003\uff09: Angioimmunoblastic T-cell lymphoma\u306e1\u4f8b\uff0e\u81e8\u5e8a\u76ae\u819a\u79d1 57 \uff086\uff09: 519\u2212522"},{"key":"19","unstructured":"19 . \u83ca\u6c60\u667a\uff082003\uff09: \u3010\u76ae\u819a\u79d1\u533b\u306e\u305f\u3081\u306e\u30ea\u30f3\u30d1\u816b\u306e\u75c5\u7406\u30fb\u907a\u4f1d\u5b50\u8a3a\u65ad\u30de\u30cb\u30e5\u30a2\u30eb\u3011AILD\u306e\u75c5\u614b\u3068\u8a3a\u65ad\uff0eDerma \uff0871\uff09: 53\u221260"},{"key":"20","unstructured":"20 . \u5c0f\u6797\u771f\u5df1\uff0c\u5927\u897f\u5584\u535a\uff0c\u85e4\u672c\u5178\u5b8f\uff0c\u5409\u6c38\u82f1\u53f8\uff0c\u591a\u5cf6\u65b0\u543e\uff082005\uff09: \u518d\u71c3\u6642\u7279\u7570\u75b9\u3092\u751f\u3058\u305f\u8840\u7ba1\u514d\u75ab\u82bd\u7403T\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b\uff0e\u76ae\u819a\u79d1\u306e\u81e8\u5e8a 47 \uff086\uff09: 882\u2212885"},{"key":"21","unstructured":"21 . \u6c38\u5c3e\u9ebb\u7531\u5b50\uff0c\u6589\u85e4\u6566\uff0c\u4e2d\u9808\u4e00\u90ce\uff0c\u539f\u7530\u662d\u4e00\u90ce\uff0c\u51fa\u6708\u5065\u592b\uff0c\u4e94\u5341\u5d50\u6566\u4e4b\uff082006\uff09: Angioimmunoblastic T-Cell Lymphoma\u306e1\u4f8b\uff0e\u76ae\u819a\u79d1\u306e\u81e8\u5e8a 48\uff085\uff09:697\u2212699"},{"key":"22","unstructured":"22 . \u52dd\u91ce\u6b63\u5b50\uff0c\u5ca1\u91ce\u7d75\u91cc\u5b50\uff0c\u6238\u5009\u5e83\u4e00\uff0c\u4ed6\uff082000\uff09: \u3010\u30ea\u30f3\u30d5\u30a9\u30fc\u30de\u30fb\u767d\u8840\u75c5\u3011\u4e2d\u6bd2\u75b9\u304c\u521d\u767a\u75c7\u72b6\u3067\u3042\u3063\u305f\u8840\u7ba1\u514d\u75ab\u82bd\u7403\u6027T\u7d30\u80de\u30ea\u30f3\u30d1\u816b\uff0e\u76ae\u819a\u79d1\u306e\u81e8\u5e8a 42 \uff084\uff09: 567\u2212570"},{"key":"23","unstructured":"23 . \u65b0\u7530\u60a0\u7d00\u5b50\uff0c\u5009\u6a4b\u76f4\u5b50\uff0c\u5c0f\u6c60\u6587\u7f8e\u9999\uff0c\u4ed6\uff082007\uff09: \u7279\u7570\u306a\u76ae\u75b9\u3092\u5448\u3057\u305fangioimmunoblastic T-cell lymphoma\u306e2\u4f8b\uff0e\u81e8\u5e8a\u76ae\u819a\u79d1 61 \uff089\uff09: 673\u2212678"},{"key":"24","unstructured":"24 . \u6642\u7530\u667a\u5b50\uff0c\u85e4\u5cf6\u884c\u8f1d\uff0c\u6cbc\u5ca1\u82f1\u6674\uff0c\u53ca\u5ddd\u9686\u559c\uff0c\u7b39\u751f\u4fca\u4e00\uff0c\u8d64\u5742\u4fca\uff082009\uff09: \u7d05\u6591\u304c\u5148\u884c\u3057\u305fangioimmunoblastic T-cell lymphoma (AITL)\u306e1\u4f8b\uff0e\u81e8\u5e8a\u76ae\u819a\u79d1 63\uff088\uff09: 597\u2212601"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 . \u82b1\u8f2a\u66f8\u7d75\uff0c\u51fa\u53e3\u9806\u5553\uff0c\u5b89\u85e4\u5178\u5b50\uff0c\u4ed6\uff082010\uff09: AGEP\u3092\u4f34\u3063\u305fangioimmunoblastic T-cell lymphoma (AITL)\u306e1\u4f8b\uff0eSkin Cancer 25 \uff082\uff09: 150\u2212156","DOI":"10.5227\/skincancer.25.150"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 . \u9234\u6728\u898f\u5f18\uff0c\u9234\u6728\u5927\u4ecb\uff0c\u85e4\u7530\u6df3\u53f2\uff0c\u4ed6\uff082011\uff09: \u4e2d\u6bd2\u75b9\u69d8\u76ae\u75b9\uff0c\u591a\u30af\u30ed\u30fc\u30f3\u6027\u9ad8\u30ac\u30f3\u30de\u30b0\u30ed\u30d6\u30ea\u30f3\u8840\u75c7\uff0c\u9aa8\u9ac4\u6d78\u6f64\u3092\u4f34\u3063\u305fangioimmunoblastic T-cell lymphoma\u306e1\u4f8b\uff0eSkin Cancer 26 \uff082\uff09: 134\u2212138","DOI":"10.5227\/skincancer.26.134"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 . \u5c0f\u8597\u53ef\u5948\uff0c\u5c71\u6751\u548c\u5f66\uff0c\u5897\u91ce\u5e74\u5f66\uff0c\u53e4\u6c5f\u5897\u9686\uff0c\u9ebb\u5965\u82f1\u6bc5\uff0c\u85e4\u539f\u6075 \uff082012\uff09: \u76ae\u75b9\u3092\u4f34\u3063\u305fAngioimmunoblastic T-cell Lymphoma\u306e2\u4f8b\uff0e\u897f\u65e5\u672c\u76ae\u819a\u79d1 74 \uff084\uff09: 399\u2212404","DOI":"10.2336\/nishinihonhifu.74.399"},{"key":"28","unstructured":"28 . \u6960\u8449\u5c55\u5927\uff0c\u5927\u6a4b\u7406\u52a0\uff0c\u8fbb\u5ca1\u99a8\uff082012\uff09: A case of angioimmunoblastic T cell lymphoma associated with paraneoplastic acral vascular syndrome. \u81e8\u5e8a\u76ae\u819a\u79d1 66 \uff086\uff09: 452\u2212456"},{"key":"29","unstructured":"29 . \u65b0\u4e95\u5d07\uff0c\u8c37\u6d25\u7483\u6075\uff0c\u5ba4\u7e6d\u5b50\uff0c\u4e09\u6a4b\u5584\u6bd4\u53e4\uff0c\u576a\u4e95\u826f\u6cbb \uff082014\uff09: \u3010\u7db2\u72b6\u3092\u5448\u3059\u308b\u76ae\u819a\u75be\u60a3\u3011&lt;\u81e8\u5e8a\u4f8b&gt;\u3000\u8840\u7ba1\u514d\u75ab\u82bd\u7403\u6027T\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u3092\u5408\u4f75\u3057\u305fIgG4\u95a2\u9023\u75be\u60a3\u3000\u7db2\u72b6\u76ae\u6591\u3068\u58ca\u6b7b\u6027\u8840\u7ba1\u708e\u3092\u5448\u3057\u305f\u4f8b\uff0e\u76ae\u819a\u75c5\u8a3a\u7642 36 \uff083\uff09: 263\u2212266"},{"key":"30","unstructured":"30 . \u732a\u718a\u5927\u8f14\uff0c\u53e4\u53e3\u83ef\u5b50\uff0c\u6e21\u9089\u7f8e\u4f73\uff0c\u83ca\u5730\u4e00\u535a\uff0c\u571f\u5c4b\u559c\u4e45\u592b\uff0c\u6e05\u6c34\u8061\u5b50\uff0c\u5742\u4e95\u4fca\u54c9\uff0c\u67f3\u5185\u5145\uff0c\u8fbb\u9686\u88d5\uff0c\u6df1\u6fa4\u96c4\u4e00\u90ce\uff082014\uff09: \u8840\u7ba1\u514d\u75ab\u82bd\u7403\u6027T\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b\uff0e\u81e8\u5e8a\u76ae\u819a\u79d1 68\uff087\uff09: 535\u2212539"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 . Saito K, Okiyama N, Shibao K, Maruyama H & Fujimoto M (2016): Angioimmunoblastic T-cell lymphoma mimicking dermatomyositis.  J Dermatol 43 \uff087\uff09: 837\u2212839","DOI":"10.1111\/1346-8138.13299"},{"key":"32","unstructured":"32 . \u7b95\u8f2a\u667a\u5e78\uff0c\u67f3\u6fa4\u5065\u4e8c\uff0c\u52a0\u8cc0\u8c37\u771f\u8d77\u5b50\uff0c\u9ad8\u6a4b\u535a\u4e4b\uff0c\u4e95\u7aef\u6df3\uff0c\u5f8c\u85e4\u7530\u88d5\u5b50\uff082018\uff09: Angioimmunoblastic T-cell Lymphoma\u306e1\u4f8b\uff0e\u897f\u65e5\u672c\u76ae\u819a\u79d1 80 \uff081\uff09: 38\u221244"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 . Ortonne N, Dupuis J, Plonquet A <i>et al <\/i>(2007): Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL).  Am J Surg Pathol 31 (7): 1068\u22121076","DOI":"10.1097\/PAS.0b013e31802df4ef"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 . Schmuth Matthias, Ramaker Jutta, Trautmann Christoph <i>et al<\/i> (1997): Cutaneous involvement in prelymphomatous angioimmunoblastic lymphadenopathy.  J Am Acad Dermatol 36 (2, Part 2): 290\u2212295","DOI":"10.1016\/S0190-9622(97)80401-X"}],"container-title":["Journal of UOEH"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/44\/3\/44_293\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T05:05:22Z","timestamp":1662786322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/juoeh\/44\/3\/44_293\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.7888\/juoeh.44.293","relation":{},"ISSN":["0387-821X","2187-2864"],"issn-type":[{"value":"0387-821X","type":"print"},{"value":"2187-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]}}}